Score Breakdown
Offering Ability
60
Cash Runway
95
Float Risk
82
Warrant Exposure
15
Convertible Debt
40
Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
model est. 32%
💰 Capital Raise
model 55%
• Critical: only 0.1 months cash remaining
📉 Score Deterioration
model 15%
• Score already CRITICAL (79/100) — events likely imminent
Market Data
Market Cap$782.71M
Shares Outstanding230.21M
Float29.71M
Cash$39.0K
Debt$19.68M
Short InterestN/A
Institutional Holdings
0.0% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest93.4K
Days to Cover3.6
% of Float0.3%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL WARRANT
2026-06-30
xbrl
XBRL CONVERTIBLE
2022-09-30
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual SMNR Dilution Snapshot
Semnur Pharmaceuticals, Inc. (SMNR) has a DilutionScore of 79/100, rated Critical dilution risk. Score date: August 28, 2026.
- Stored outstanding warrants: 7.4M.
- Recent SEC activity tracked for SMNR: xbrl on 2026-06-30; xbrl on 2022-09-30.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — CRITICAL Risk
Other CRITICAL dilution risk stocks tracked by DilutionWatch with similar profiles: